Apicidin decreases phospholipase C gamma-1 transcript and protein in Hut-78 T lymphoma cells

Biomedicine and Pharmacotherapy

Volumn 63, Issue 7, 2009, Pages 543-547

  Debicki, Szymon ^a   Jagodzinski, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Apicidin; Histone deacetylase inhibitors; Hut 78 T lymphoma cells

Indexed keywords

APICIDIN; MESSENGER RNA; PHOSPHOLIPASE C GAMMA1;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG MECHANISM; GENETIC STABILITY; HALF LIFE TIME; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; HISTONE DEACETYLASE INHIBITORS; LYMPHOMA, T-CELL; PEPTIDES, CYCLIC; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RABBITS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 68049084545     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.09.008     Document Type: Article

References (37)

1. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., et al. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 16 (1998) 523-544
2. Weiss A., and Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell 76 (1994) 263-274
3. Desai D.M., Newton M.E., Kadlecek T., and Weiss A. Stimulation of the phosphatidylinositol pathway can induce T-cell activation. Nature 348 (1990) 66-69
4. Bunnell S.C., Diehn M., Yaffe M.B., Findell P.R., Cantley L.C., and Berg L.J. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J Biol Chem 275 (2000) 2219-2230
5. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., and Samelson L.E. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92 (1998) 83-92
6. Bonvini E., DeBell K.E., Veri M.C., Graham L., Stoica B., Laborda J., et al. On the mechanism coupling phospholipase Cgamma1 to the B- and T-cell antigen receptors. Adv Enzyme Regul 43 (2003) 245-269
7. Katan M. Families of phosphoinositide-specific phospholipase C: structure and function. Biochim Biophys Acta 1436 (1998) 5-17
8. Ebinu J.O., Stang S.L., Teixeira C., Bottorff D.A., Hooton J., Blumberg P.M., et al. RasGRP links T-cell receptor signaling to Ras. Blood 95 (2000) 3199-3203
9. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70 (2001) 281-312
10. Richardson B., and Yung R. Role of DNA methylation in the regulation of cell function. J Lab Clin Med 134 (1999) 333-340
11. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., and Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 983 (2003) 84-100
12. Luczak M.W., and Jagodzinski P.P. The role of DNA methylation in cancer development. Folia Histochem Cytobiol 44 (2006) 143-154
13. Acharya M.R., Sparreboom A., Venitz J., and Figg W.D. Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol Pharmacol 68 (2005) 917-932
14. Li N., Zhao D., Kirschbaum M., Zhang C., Lin C.L., Todorov I., et al. HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen. Proc Natl Acad Sci U S A 105 (2008) 4796-4801
15. Mishra N., Reilly C.M., Brown D.R., Ruiz P., and Gilkeson G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 111 (2003) 539-552
16. + T cell responses. BMC Cancer 3 (2003) 30
17. Tao R., and Hancock W.W. Regulating regulatory T cells to achieve transplant tolerance. Hepatobiliary Pancreat Dis Int 6 (2007) 348-357
18. Han J.W., Ahn S.H., Park S.H., Wang S.Y., Bae G.U., Seo D.W., et al. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res 60 (2000) 6068-6074
19. Kim S., Kang J.K., Kim Y.K., Seo D.W., Ahn S.H., Lee J.C., et al. Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites. Biochem Biophys Res Commun 342 (2006) 1168-1173
20. Kim Y.K., Seo D.W., Kang D.W., Lee H.Y., Han J.W., and Kim S.N. Involvement of HDAC1 and the PI3K/PKC signaling pathways in NF-kappaB activation by the HDAC inhibitor apicidin. Biochem Biophys Res Commun 347 (2006) 1088-1093
21. You J.S., Kang J.K., Lee E.K., Lee J.C., Lee S.H., Jeon Y.J., et al. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells. Oncogene 27 (2008) 1376-1386
22. Kim S.H., Jeong J.W., Park J.A., Lee J.W., Seo J.H., Jung B.K., et al. Regulation of the HIF-1alpha stability by histone deacetylases. Oncol Rep 17 (2007) 647-651
23. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
24. Xie J.F., Stroumza J., and Graves D.T. IL-1 down-regulates platelet-derived growth factor-alpha receptor gene expression at the transcriptional level in human osteoblastic cells. J Immunol 153 (1994) 378-383
25. Drummond D.C., Noble C.O., Kirpotin D.B., Guo Z., Scott G.K., and Benz C.C. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 45 (2005) 495-528
26. Darkin-Rattray S.J., Gurnett A.M., Myers R.W., Dulski P.M., Crumley T.M., Allocco J.J., et al. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc Natl Acad Sci U S A 93 (1996) 13143-13147
27. Singh S.B., Zink D.L., Liesch J.M., Dombrowski A.W., Darkin-Rattray S.J., Schmatz D.M., et al. Structure, histone deacetylase, and antiprotozoal activities of apicidins B and C, congeners of apicidin with proline and valine substitutions. Org Lett 3 (2001) 2815-2818
28. Singh S.B., Zink D.L., Liesch J.M., Mosley R.T., Dombrowski A.W., Bills G.F., et al. Structure and chemistry of apicidins, a class of novel cyclic tetrapeptides without a terminal alpha-keto epoxide as inhibitors of histone deacetylase with potent antiprotozoal activities. J Org Chem 67 (2002) 815-825
29. Khan N., Jeffers M., Kumar S., Hackett C., Boldog F., Khramtsov N., et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409 (2008) 581-589
30. Han J.W., Ahn S.H., Kim Y.K., Bae G.U., Yoon J.W., Hong S., et al. Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C. J Biol Chem 276 (2001) 42084-42090
31. Kim Y.K., Han J.W., Woo Y.N., Chun J.K., Yoo J.Y., Cho E.J., et al. Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway. Oncogene 22 (2003) 6023-6031
32. Cheong J.W., Chong S.Y., Kim J.Y., Eom J.I., Jeung H.K., Maeng H.Y., et al. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Clin Cancer Res 9 (2003) 5018-5027
33. Kim S.H., Ahn S., Han J.W., Lee H.W., Lee H.Y., Lee Y.W., et al. Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials. Biochem Biophys Res Commun 315 (2004) 964-970
34. Januchowski R., Dabrowski M., Ofori H., and Jagodzinski P.P. Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells. Cancer Lett 246 (2007) 313-317
35. Januchowski R., and Jagodzinski P.P. Trichostatin A down-regulates ZAP-70, LAT and SLP-76 content in Jurkat T cells. Int Immunopharmacol 7 (2007) 198-204
36. Xiong Y., Dowdy S.C., Podratz K.C., Jin F., Attewell J.R., Eberhardt N.L., et al. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Cancer Res 65 (2005) 2684-2689
37. Mishra N., Brown D.R., Olorenshaw I.M., and Kammer G.M. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. Proc Natl Acad Sci U S A 98 (2001) 2628-2633